Eric Topol, MD highlights the expanding role of AI in mammography — enhancing detection performance, streamlining workflows, and enabling more consistent evaluation of imaging findings already present in the exam.

At CureMetrix, we share this vision. cmAngio, a FDA-cleared software is designed for detection of breast arterial calcification (BAC) and is currently deployed at 350+ sites. Our work focuses on helping turn a routine mammogram into a 2-for-1 exam—supporting cancer detection while also identifying breast arterial calcifications (BAC) from the same images.

BAC also remains an active area of clinical research. A growing body of scientific literature, including studies referenced here, has explored potential associations with cardiovascular health. These investigations reflect ongoing research distinct from the device’s cleared detection indication.

Read more here.